BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 25724390)

  • 1. Peptide length and folding state govern the capacity of staphylococcal β-type phenol-soluble modulins to activate human formyl-peptide receptors 1 or 2.
    Kretschmer D; Rautenberg M; Linke D; Peschel A
    J Leukoc Biol; 2015 Apr; 97(4):689-97. PubMed ID: 25724390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Determinants in the
    Viklund M; Fredriksson J; Holdfeldt A; Lind S; Franzyk H; Dahlgren C; Sundqvist M; Forsman H
    J Immunol; 2022 Apr; 208(7):1632-1641. PubMed ID: 35321878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil responses to staphylococcal pathogens and commensals via the formyl peptide receptor 2 relates to phenol-soluble modulin release and virulence.
    Rautenberg M; Joo HS; Otto M; Peschel A
    FASEB J; 2011 Apr; 25(4):1254-63. PubMed ID: 21183593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The virulence regulator Agr controls the staphylococcal capacity to activate human neutrophils via the formyl peptide receptor 2.
    Kretschmer D; Nikola N; Dürr M; Otto M; Peschel A
    J Innate Immun; 2012; 4(2):201-12. PubMed ID: 22067547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The leukocyte chemotactic receptor FPR2, but not the closely related FPR1, is sensitive to cell-penetrating pepducins with amino acid sequences descending from the third intracellular receptor loop.
    Forsman H; Bylund J; Oprea TI; Karlsson A; Boulay F; Rabiet MJ; Dahlgren C
    Biochim Biophys Acta; 2013 Aug; 1833(8):1914-23. PubMed ID: 23562731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural changes of the ligand and of the receptor alters the receptor preference for neutrophil activating peptides starting with a formylmethionyl group.
    Forsman H; Winther M; Gabl M; Skovbakke SL; Boulay F; Rabiet MJ; Dahlgren C
    Biochim Biophys Acta; 2015 Jan; 1853(1):192-200. PubMed ID: 25447672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitocryptide-2: Identification of Its Minimum Structure for Specific Activation of FPR2-Possible Receptor Switching from FPR2 to FPR1 by Its Physiological C-terminal Cleavages.
    Marutani T; Nishino K; Miyaji T; Kamada K; Ohura K; Kiso Y; Mukai H
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enterococcus faecium stimulates human neutrophils via the formyl-peptide receptor 2.
    Bloes DA; Otto M; Peschel A; Kretschmer D
    PLoS One; 2012; 7(6):e39910. PubMed ID: 22768166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural characterization and inhibitory profile of formyl peptide receptor 2 selective peptides descending from a PIP2-binding domain of gelsolin.
    Forsman H; Andréasson E; Karlsson J; Boulay F; Rabiet MJ; Dahlgren C
    J Immunol; 2012 Jul; 189(2):629-37. PubMed ID: 22706076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formyl-peptide receptor 2 governs leukocyte influx in local
    Weiss E; Hanzelmann D; Fehlhaber B; Klos A; von Loewenich FD; Liese J; Peschel A; Kretschmer D
    FASEB J; 2018 Jan; 32(1):26-36. PubMed ID: 28855276
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Sundqvist M; Christenson K; Gabl M; Holdfeldt A; Jennbacken K; Møller TC; Dahlgren C; Forsman H
    J Immunol; 2019 Dec; 203(12):3349-3360. PubMed ID: 31694908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The FPR2-specific ligand MMK-1 activates the neutrophil NADPH-oxidase, but triggers no unique pathway for opening of plasma membrane calcium channels.
    Karlsson J; Stenfeldt AL; Rabiet MJ; Bylund J; Forsman HF; Dahlgren C
    Cell Calcium; 2009 May; 45(5):431-8. PubMed ID: 19282028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A neutrophil inhibitory pepducin derived from FPR1 expected to target FPR1 signaling hijacks the closely related FPR2 instead.
    Winther M; Gabl M; Welin A; Dahlgren C; Forsman H
    FEBS Lett; 2015 Jul; 589(15):1832-9. PubMed ID: 26071379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The proteolytically stable peptidomimetic Pam-(Lys-βNSpe)6-NH2 selectively inhibits human neutrophil activation via formyl peptide receptor 2.
    Skovbakke SL; Heegaard PM; Larsen CJ; Franzyk H; Forsman H; Dahlgren C
    Biochem Pharmacol; 2015 Jan; 93(2):182-95. PubMed ID: 25462815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of C-terminal phosphorylation sites of N-formyl peptide receptor-1 (FPR1) in human blood neutrophils.
    Maaty WS; Lord CI; Gripentrog JM; Riesselman M; Keren-Aviram G; Liu T; Dratz EA; Bothner B; Jesaitis AJ
    J Biol Chem; 2013 Sep; 288(38):27042-27058. PubMed ID: 23873933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural determinants for the interaction of formyl peptide receptor 2 with peptide ligands.
    He HQ; Troksa EL; Caltabiano G; Pardo L; Ye RD
    J Biol Chem; 2014 Jan; 289(4):2295-306. PubMed ID: 24285541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signal inhibitory receptor on leukocytes-1 recognizes bacterial and endogenous amphipathic α-helical peptides.
    Rumpret M; von Richthofen HJ; van der Linden M; Westerlaken GHA; Talavera Ormeño C; van Strijp JAG; Landau M; Ovaa H; van Sorge NM; Meyaard L
    FASEB J; 2021 Oct; 35(10):e21875. PubMed ID: 34533845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel small-molecule agonists for human formyl peptide receptors and pharmacophore models of their recognition.
    Kirpotina LN; Khlebnikov AI; Schepetkin IA; Ye RD; Rabiet MJ; Jutila MA; Quinn MT
    Mol Pharmacol; 2010 Feb; 77(2):159-70. PubMed ID: 19903830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human formyl peptide receptor 2 senses highly pathogenic Staphylococcus aureus.
    Kretschmer D; Gleske AK; Rautenberg M; Wang R; Köberle M; Bohn E; Schöneberg T; Rabiet MJ; Boulay F; Klebanoff SJ; van Kessel KA; van Strijp JA; Otto M; Peschel A
    Cell Host Microbe; 2010 Jun; 7(6):463-73. PubMed ID: 20542250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrin-releasing peptide/neuromedin B receptor antagonists PD176252, PD168368, and related analogs are potent agonists of human formyl-peptide receptors.
    Schepetkin IA; Kirpotina LN; Khlebnikov AI; Jutila MA; Quinn MT
    Mol Pharmacol; 2011 Jan; 79(1):77-90. PubMed ID: 20943772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.